GO:0071949 FAD binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071949 FAD binding describes the molecular function of binding the oxidized form of flavin adenine dinucleotide (FAD), a coenzyme or prosthetic group of many flavoprotein oxidoreductases.
• FAD binding is essential for the catalytic activity of diverse enzymes, including glutathione reductase, urate oxidase (XO), and GMC-oxidoreductases [6, 2, 1].
• FAD-binding domains such as the BLUF domain mediate sensory transduction in microorganisms, linking redox chemistry to light perception.
• Computational tools like FAD-BERT enable accurate prediction of FAD-binding sites from protein sequences, accelerating functional annotation.
• Mutations affecting FAD binding can alter enzyme stability, chaperone activity, and oxidative stress tolerance, as shown for Arabidopsis YUCCA6.
• FAD binding is a validated drug target; for example, delphinidin-3-glucoside lowers urate by binding to the FAD site of xanthine oxidase.
Description
FAD binding (GO:0071949) is a molecular function defined as the binding to the oxidized form of flavin adenine dinucleotide (FAD), the coenzyme or prosthetic group of various flavoprotein oxidoreductase enzymes. This function is fundamental to redox biology, as FAD serves as a versatile electron carrier in numerous metabolic pathways, including oxidative phosphorylation, fatty acid oxidation, and detoxification. The importance of FAD binding extends across all kingdoms of life, from bacterial sensory proteins to human metabolic enzymes [3, 6]. Understanding the structural and mechanistic basis of FAD binding is critical for drug discovery, enzyme engineering, and deciphering disease-associated mutations [2, 7]. Recent advances in deep learning, such as FAD-BERT, have improved our ability to predict FAD-binding sites, facilitating the annotation of uncharacterized proteins. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of FAD binding, its key genes, regulatory aspects, disease relevance, and experimental models for research.
FAD binding At A Glance
| GO ID | GO:0071949 |
|---|---|
| GO term | FAD binding |
| Ontology | molecular_function |
| Synonym | oxidized flavin adenine dinucleotide binding, oxidized flavine-adenine dinucleotide binding |
| Major function | Binding to the oxidized form of FAD, enabling electron transfer in oxidoreductases |
| Definition source | QuickGO |
| Related cofactor | FAD (flavin adenine dinucleotide, oxidized form) |
| Representative enzymes | Glutathione reductase, xanthine oxidase, GMC-oxidoreductases, BLUF domain proteins |
What Is GO:0071949?
FAD binding is the molecular function of selectively interacting with the oxidized form of flavin adenine dinucleotide (FAD), a coenzyme or prosthetic group found in many flavoprotein oxidoreductases. This binding event is typically non-covalent but can also involve covalent attachment, and it is essential for the catalytic activity of enzymes that transfer electrons from substrates to FAD, which then donates them to downstream acceptors. The term encompasses both transient binding during catalysis and stable prosthetic group association.
Why Is FAD binding Important in Cell Biology?
FAD binding is central to cellular redox homeostasis and energy metabolism, as it enables enzymes to catalyze essential oxidation-reduction reactions. Defects in FAD binding can lead to loss of enzyme activity, accumulation of toxic metabolites, and increased oxidative stress, contributing to metabolic disorders, cancer, and neurodegeneration [6, 7, 2]. Moreover, FAD-binding proteins are attractive drug targets, and understanding their binding mechanisms can guide the development of inhibitors or modulators. The widespread occurrence of FAD-binding domains across diverse protein families underscores their evolutionary significance and functional versatility [8, 3].
• FAD binding is required for the catalytic activity of many oxidoreductases involved in energy production and detoxification.
• Mutations in FAD-binding domains are associated with human diseases such as glutathione reductase deficiency and xanthinuria [6, 2].
• FAD-binding proteins participate in sensory transduction, as exemplified by BLUF domain photoreceptors.
• The FAD-binding site of xanthine oxidase is a target for urate-lowering compounds, relevant to gout treatment.
• FAD binding modulates chaperone activity and oxidative stress tolerance in plants, with implications for crop resilience.
• Computational prediction of FAD-binding sites aids in functional annotation of genomes and metagenomes.
• FAD binding is essential for the biosynthesis of hormones and secondary metabolites, such as auxin in plants.
• Understanding FAD binding facilitates enzyme engineering for biocatalysis and synthetic biology.
• FAD-binding domains are structurally conserved, providing insights into protein evolution and folding.
• FAD binding is a key parameter in drug design, as many therapeutic agents act by competing with FAD.
What Happens During FAD binding?
FAD Recognition and Initial Binding
In simple terms: The protein first recognizes and loosely grabs the FAD molecule.
FAD binding begins with the specific recognition of the oxidized FAD molecule by a conserved binding pocket within the target protein. This pocket typically contains aromatic residues that stack against the isoalloxazine ring of FAD, as well as hydrogen-bond donors and acceptors that interact with the adenine and ribose moieties. For example, in glutathione reductase, the FAD-binding domain forms a Rossmann-like fold that positions the isoalloxazine ring for optimal electron transfer. In GMC-oxidoreductases, the binding process involves conformational changes that lock FAD into place.
Conformational Changes and Stabilization
In simple terms: The protein changes shape to hold FAD tightly and stably.
Upon initial binding, many FAD-binding proteins undergo conformational rearrangements that stabilize the cofactor and prepare the active site for catalysis. In the tryptophan 6-halogenase Thal, binding of FAD and tryptophan is negatively coupled, meaning that the presence of one ligand affects the binding of the other, highlighting allosteric regulation. Similarly, in YUCCA6 from Arabidopsis, FAD binding is essential for chaperone activity and oxidative stress tolerance, and mutations in the FAD-binding site impair these functions.
Catalytic Activation and Electron Transfer
In simple terms: Once FAD is bound, the enzyme can start moving electrons to do its job.
The bound FAD serves as a redox center that accepts electrons from a substrate and donates them to an electron acceptor. In xanthine oxidase, FAD binding is required for the oxidation of xanthine to uric acid, and compounds that bind to the FAD site can inhibit this activity. In GMC-oxidoreductases, FAD binding and dissociation are tightly regulated to control catalytic turnover. The redox potential of FAD is modulated by the protein environment, allowing fine-tuning of enzyme activity.
FAD Dissociation and Recycling
In simple terms: After the reaction, FAD can be released so the protein can be reused or regulated.
FAD can dissociate from the protein, either as part of a regulatory cycle or when the protein is degraded. In GMC-oxidoreductases, FAD binding and dissociation are dynamic processes that influence enzyme stability and activity. In some sensory proteins, such as those containing BLUF domains, FAD remains bound but undergoes light-induced conformational changes that alter signaling. The balance between bound and free FAD is critical for cellular redox homeostasis.
Key Genes Involved in GO:0071949 FAD binding
The following genes encode proteins that bind FAD and are representative of the diverse functions associated with GO:0071949.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GSR | Glutathione reductase; binds FAD to reduce oxidized glutathione | Deficiency causes hemolytic anemia; model for FAD-binding domain studies |
| XDH | Xanthine dehydrogenase/oxidase; binds FAD to oxidize xanthine | Target for gout and hyperuricemia; FAD site binds inhibitors |
| YUCCA6 | Flavin monooxygenase; binds FAD for auxin biosynthesis and chaperone activity | Role in oxidative stress tolerance in plants |
| Thal | Tryptophan 6-halogenase; binds FAD for halogenation | Model for coupled ligand binding and enzyme mechanism |
| BLUF domain proteins | Bind FAD for blue-light sensing | Sensory transduction in microorganisms |
| GMC-oxidoreductases | Family of FAD-binding oxidoreductases | FAD binding/dissociation dynamics; biocatalysis |
| FAD-BERT targets | Computationally predicted FAD-binding proteins | Machine learning for binding site prediction |
| ETFA | Electron transfer flavoprotein alpha; binds FAD | Mitochondrial fatty acid oxidation; disease mutations |
| ETFB | Electron transfer flavoprotein beta; binds FAD | Glutaric acidemia type II |
| ACADM | Medium-chain acyl-CoA dehydrogenase; binds FAD | Fatty acid oxidation disorders |
| SDHA | Succinate dehydrogenase complex flavoprotein subunit A; binds FAD | Mitochondrial complex II; cancer and myopathy |
| MTHFR | Methylenetetrahydrofolate reductase; binds FAD | Folate metabolism; cardiovascular disease |
| NOS2 | Inducible nitric oxide synthase; binds FAD | Inflammation and cancer |
| POR | Cytochrome P450 oxidoreductase; binds FAD and FMN | Drug metabolism; congenital adrenal hyperplasia |
| NQO1 | NAD(P)H quinone dehydrogenase 1; binds FAD | Cancer chemoprevention; redox cycling |
| DAO | D-amino acid oxidase; binds FAD | Neurodegeneration; schizophrenia |
| MAOB | Monoamine oxidase B; binds FAD | Parkinson's disease; drug target |
How Is FAD binding Regulated?
FAD binding is regulated at multiple levels. The availability of FAD, which is synthesized from riboflavin, directly influences the saturation of FAD-binding proteins. In GMC-oxidoreductases, FAD binding and dissociation are governed by conformational dynamics and ligand-induced changes. In Thal, binding of FAD and tryptophan is negatively coupled, indicating allosteric regulation. Additionally, post-translational modifications and oxidative stress can affect the redox state of FAD and its binding affinity. In plants, YUCCA6 chaperone activity depends on FAD and NADPH binding, linking metabolic status to stress responses.
FAD binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GSR | Glutathione reductase deficiency; hemolytic anemia | Knockout or point-mutation in erythroid cell lines |
| XDH | Hyperuricemia and gout | Knock-in of human XDH in mouse models; enzyme assays |
| YUCCA6 | Oxidative stress tolerance in plants | Arabidopsis knockout and overexpression lines |
| MAOB | Parkinson's disease | Neuronal cell models with MAOB knockout or point mutations |
| NQO1 | Cancer susceptibility and chemoprevention | Cancer cell lines with NQO1 knockout or overexpression |
FAD Binding in Metabolic Disorders
Defects in FAD binding can lead to metabolic diseases. For instance, mutations in glutathione reductase (GSR) that impair FAD binding cause glutathione reductase deficiency, characterized by hemolytic anemia and increased oxidative stress. Similarly, xanthine oxidase (XO) requires FAD binding for activity; excessive XO activity contributes to hyperuricemia and gout, and inhibitors that target the FAD site are used therapeutically.
FAD Binding in Cancer and Oxidative Stress
FAD-binding proteins such as NQO1 and NOS2 play roles in cancer. NQO1 binds FAD to detoxify quinones, and its polymorphism affects cancer susceptibility. In Arabidopsis, YUCCA6 FAD binding is essential for chaperone activity and oxidative stress tolerance, suggesting that similar mechanisms may protect cells from stress-induced damage. Targeting FAD-binding sites in cancer cells is a potential therapeutic strategy.
FAD Binding in Neurodegeneration
Monoamine oxidase B (MAOB) binds FAD and is involved in dopamine metabolism; inhibitors of MAOB are used in Parkinson's disease. D-amino acid oxidase (DAO) binds FAD and regulates neurotransmitter levels, with implications for schizophrenia. Thus, FAD binding is a key determinant of neurological function and disease.
From FAD binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of FAD binding abolish enzyme activity? | CRISPR knockout of the FAD-binding domain |
| How does a disease-associated point mutation affect FAD binding? | Point-mutation knock-in cell lines |
| Can a tagged FAD-binding protein be used for localization studies? | Knock-in of fluorescent or affinity tags |
| Does overexpression of a FAD-binding protein alter redox balance? | Overexpression cell models |
| Which genes are essential for FAD binding in a pathway? | CRISPR library screening |
| What is the structural basis of FAD binding? | Recombinant protein expression and crystallography |
How to Study the FAD binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Atomic structure of FAD-protein complex | Determining binding mode and conformational changes |
| Isothermal titration calorimetry | Binding affinity and thermodynamics | Quantifying effects of mutations on FAD binding |
| FAD-BERT prediction | Probability of FAD-binding sites | Annotating novel proteins from sequence |
| Enzymatic activity assay | Catalytic turnover dependent on FAD | Assessing functional impact of FAD-binding mutations |
| CRISPR knockout | Loss-of-function phenotype | Validating gene essentiality for FAD-dependent pathways |
| CRISPR point mutation | Effect of specific amino acid changes | Modeling disease-associated variants |
| Overexpression | Gain-of-function and stress response | Studying redox imbalance and chaperone activity |
| CRISPR library screening | Identification of genes required for FAD binding | High-throughput functional genomics |
Structural and Biophysical Methods
X-ray crystallography and cryo-EM can resolve the atomic details of FAD binding, as demonstrated for glutathione reductase and GMC-oxidoreductases [6, 1]. Isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) measure binding affinity and kinetics. These methods are essential for understanding how mutations affect FAD binding.
Computational Prediction and Machine Learning
Tools like FAD-BERT use deep learning to predict FAD-binding sites from sequence data, enabling rapid annotation of uncharacterized proteins. Molecular dynamics simulations can model FAD binding and dissociation pathways.
Functional Assays and Cellular Models
Enzymatic assays measuring NADPH oxidation or substrate conversion can assess FAD-binding activity. CRISPR knockout and point-mutation cell lines allow functional validation of FAD-binding residues. Oxidative stress tolerance assays in Arabidopsis YUCCA6 mutants link FAD binding to stress responses.
Omics and Screening Approaches
Transcriptomics and proteomics can identify changes in FAD-binding protein expression under different conditions. CRISPR library screening can uncover genes required for FAD binding or flavoprotein function. These approaches are supported by bioinformatics pipelines for pathway enrichment.
How CRISPR Can Be Used to Study GO:0071949 FAD binding
Knockout
CRISPR knockout of genes encoding FAD-binding proteins can abolish enzyme activity and reveal cellular phenotypes. For example, knocking out GSR in cell lines leads to increased oxidative stress and sensitivity to oxidizing agents. Knockout models are essential for validating the role of FAD binding in metabolic pathways.
Point Mutation
Introducing point mutations in FAD-binding residues via CRISPR allows precise dissection of binding determinants. For instance, mutating the conserved arginine in the FAD-binding site of YUCCA6 impairs chaperone activity. Such models mimic human disease variants and help establish causality.
Knock-in
Knock-in of tagged FAD-binding proteins (e.g., GFP or HA) enables live-cell imaging and proteomic analysis. Knock-in of disease-associated mutations can recreate pathological states in isogenic cell lines. This approach is valuable for studying FAD binding in native contexts.
Overexpression
Overexpression of FAD-binding proteins can enhance enzymatic activity or induce stress responses. In Arabidopsis, YUCCA6 overexpression increases oxidative stress tolerance. Overexpression models are useful for gain-of-function studies and for producing recombinant proteins for structural analysis.
How EDITGENE Supports FAD binding Research
Researchers studying FAD binding-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, and CRISPR-based models provide the most direct way to test this. By combining knockout, point mutation, knock-in, and overexpression strategies, it is possible to dissect the precise contribution of FAD-binding residues to enzyme function and disease.
Contact EDITGENE today to design your custom CRISPR model for FAD binding research.
Frequently Asked Questions About FAD binding
What is FAD binding?
FAD binding (GO:0071949) is the molecular function of binding to the oxidized form of flavin adenine dinucleotide (FAD), a coenzyme or prosthetic group of various flavoprotein oxidoreductases.
What genes are involved in FAD binding?
Genes encoding FAD-binding proteins include GSR, XDH, YUCCA6, Thal, ETFA, ETFB, ACADM, SDHA, MTHFR, NOS2, POR, NQO1, DAO, and MAOB, among others [6, 2, 7, 4].
What diseases are associated with FAD binding defects?
Defects in FAD binding can cause glutathione reductase deficiency, hyperuricemia, gout, and may contribute to cancer, neurodegeneration, and metabolic disorders [6, 2, 8].
How can I study FAD binding in the lab?
Common methods include X-ray crystallography, ITC, enzymatic assays, and CRISPR-based knockout or point mutation models [6, 1, 7].
What is the FAD-binding domain?
The FAD-binding domain is a conserved protein fold, such as the Rossmann-like fold, that recognizes and binds FAD. Examples include the BLUF domain and the glutathione reductase FAD-binding domain [3, 6].
Can FAD binding be predicted computationally?
Yes, tools like FAD-BERT use deep learning to predict FAD-binding sites from protein sequences with high accuracy.
What is the role of FAD binding in oxidative stress?
FAD binding is essential for enzymes like glutathione reductase and YUCCA6 that combat oxidative stress; loss of binding increases sensitivity to reactive oxygen species [6, 7].
How does FAD binding affect enzyme activity?
FAD binding positions the cofactor for electron transfer; without it, enzymes cannot catalyze redox reactions, leading to loss of function [8, 1].
What are the synonyms for FAD binding?
Synonyms include oxidized flavin adenine dinucleotide binding and oxidized flavine-adenine dinucleotide binding.
Why is FAD binding important for drug discovery?
Many drugs target FAD-binding sites, such as xanthine oxidase inhibitors for gout; understanding binding mechanisms aids rational drug design.
Conclusion
FAD binding (GO:0071949) is a fundamental molecular function that underpins diverse redox processes in all domains of life. From metabolic enzymes like glutathione reductase and xanthine oxidase to sensory proteins and plant chaperones, FAD binding is critical for catalysis, regulation, and stress responses [6, 2, 7, 3]. Defects in FAD binding are linked to human diseases, making it a valuable target for therapeutic intervention. Advances in computational prediction and CRISPR-based models are accelerating research in this field [5, 7]. EDITGENE offers comprehensive services to support your FAD binding research, from knockout to library screening.
References
- 1. Ma S et al.. 2025. FAD binding and dissociation in GMC-oxidoreductases.. Int J Biol Macromol 308(Pt 1):142470 PMID: 40132288
- 2. Chen Y et al.. 2026. Urate-lowering effect of delphinidin-3-glucoside in red kidney beans via binding to the FAD site of the XO enzyme.. J Adv Res 80:555-575 PMID: 40254219
- 3. Gomelsky M et al.. 2002. BLUF: a novel FAD-binding domain involved in sensory transduction in microorganisms.. Trends Biochem Sci 27(10):497-500 PMID: 12368079
- 4. Moritzer AC et al.. 2019. Binding of FAD and tryptophan to the tryptophan 6-halogenase Thal is negatively coupled.. Protein Sci 28(12):2112-2118 PMID: 31589794
- 5. Ho QT et al.. 2021. FAD-BERT: Improved prediction of FAD binding sites using pre-training of deep bidirectional transformers.. Comput Biol Med 131:104258 PMID: 33601085
- 6. Untucht-Grau R et al.. 1981. Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain.. Eur J Biochem 120(2):407-19 PMID: 7032915
- 7. Ahn G et al.. 2025. FAD and NADPH binding sites of YUCCA6 are essential for chaperone activity and oxidative stress tolerance in Arabidopsis thaliana.. Plant Physiol Biochem 218:109335 PMID: 39603031
- 8. Dym O et al.. 2001. Sequence-structure analysis of FAD-containing proteins.. Protein Sci 10(9):1712-28 PMID: 11514662
